{
    "organizations": [],
    "uuid": "058d97c267167ce126a1b422cce71e47f62fc013",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-imprimis-pharmaceuticals-q1-revenu/brief-imprimis-pharmaceuticals-q1-revenue-rose-45-pct-to-8-9-million-idUSASC0A2E5",
    "ord_in_thread": 0,
    "title": "BRIEF-Imprimis Pharmaceuticals Q1 Revenue Rose 45 Pct To $8.9 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Imprimis Pharmaceuticals Inc:\n* IMPRIMIS PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 RESULTS\n* Q1 REVENUE ROSE 45 PERCENT TO $8.9 MILLION Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-16T04:35:00.000+03:00",
    "crawled": "2018-05-16T19:13:57.014+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "imprimis",
        "pharmaceutical",
        "inc",
        "imprimis",
        "pharmaceutical",
        "announces",
        "first",
        "quarter",
        "result",
        "q1",
        "revenue",
        "rose",
        "percent",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}